Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure

  1. Isabel Rodriguez-Barraquer  Is a corresponding author
  2. Emmanuel Arinaitwe
  3. Prasanna Jagannathan
  4. Moses R Kamya
  5. Phillip J Rosenthal
  6. John Rek
  7. Grant Dorsey
  8. Joaniter Nankabirwa
  9. Sarah G Staedke
  10. Maxwell Kilama
  11. Chris Drakeley
  12. Isaac Ssewanyana
  13. David L Smith
  14. Bryan Greenhouse
  1. University of California, San Francisco, United States
  2. Infectious Diseases Research Collaboration, Uganda
  3. Stanford University, United States
  4. Makerere University College of Health Sciences, Uganda
  5. Infectious Diseases Resarch Collaboration, Uganda
  6. London School of Hygiene and Tropical Medicine, United Kingdom
  7. University of Washington, United States

Abstract

Fundamental gaps remain in our understanding of how immunity to malaria develops. We used detailed clinical and entomological data from parallel cohort studies conducted across the malaria transmission spectrum in Uganda to quantify the development of immunity against symptomatic P. falciparum as a function of age and transmission intensity. We focus on: anti-parasite immunity (i.e; ability to control parasite densities) and anti-disease immunity (i.e; ability to tolerate higher parasite densities without fever). Our findings suggest a strong effect of age on both types of immunity, not explained by cumulative-exposure. They also show an independent effect of exposure, where children living in moderate/high transmission settings develop immunity faster as transmission increases. Surprisingly, children in the lowest transmission setting appear to develop immunity more efficiently than those living in moderate transmission settings. Anti-parasite and anti-disease immunity develop in parallel, reducing the probability of experiencing symptomatic malaria upon each subsequent P. falciparum infection.

Data availability

All the data used for these analyses as well as the R code used to reproduce the main study findings are available at https://github.com/isabelrodbar/immunity. Complete data from the 3 cohort studies are available at the CliEpiDB website (https://clinepidb.org/ce/app/record/dataset/DS_0ad509829e).

Article and author information

Author details

  1. Isabel Rodriguez-Barraquer

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    For correspondence
    isabel.rodriguez-barraquer@ucsf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6784-1021
  2. Emmanuel Arinaitwe

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  3. Prasanna Jagannathan

    Department of Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6305-758X
  4. Moses R Kamya

    Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  5. Phillip J Rosenthal

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. John Rek

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  7. Grant Dorsey

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Joaniter Nankabirwa

    Infectious Diseases Resarch Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  9. Sarah G Staedke

    London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Maxwell Kilama

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  11. Chris Drakeley

    London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4863-075X
  12. Isaac Ssewanyana

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  13. David L Smith

    Institute of Health Metrics and Evaluation, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4367-3849
  14. Bryan Greenhouse

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institutes of Health (2U19AI089674)

  • Isabel Rodriguez-Barraquer
  • Emmanuel Arinaitwe
  • Prasanna Jagannathan
  • Moses R Kamya
  • Phillip J Rosenthal
  • John Rek
  • Grant Dorsey
  • Joaniter Nankabirwa
  • Sarah G Staedke
  • Maxwell Kilama
  • Chris Drakeley
  • Isaac Ssewanyana
  • David L Smith
  • Bryan Greenhouse

Bill and Melinda Gates Foundation (OPP1110495)

  • David L Smith

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The study protocol was reviewed and approved by the Makerere University School of Medicine Research and Ethics Committee (Identification numbers 2011-149 and 2011-167, the Uganda National Council for Science and Technology, , the London School of Hygiene and Tropical Medicine Ethics Committee (Identification numbers 5943 and 5944), the Durham University School of Biological and Biomedical Sciences Ethics Committee (PRISM Entomology Uganda), and the University of California, San Francisco, Committee on Human Research (Identification numbers 11-05539 and 11-05995) and the Uganda National Council for Science and Technology (Identification numbers HS350 and HS-1019).. All parents/guardians were asked to provide written informed consent at the time of enrollment.

Copyright

© 2018, Rodriguez-Barraquer et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,671
    views
  • 625
    downloads
  • 101
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Isabel Rodriguez-Barraquer
  2. Emmanuel Arinaitwe
  3. Prasanna Jagannathan
  4. Moses R Kamya
  5. Phillip J Rosenthal
  6. John Rek
  7. Grant Dorsey
  8. Joaniter Nankabirwa
  9. Sarah G Staedke
  10. Maxwell Kilama
  11. Chris Drakeley
  12. Isaac Ssewanyana
  13. David L Smith
  14. Bryan Greenhouse
(2018)
Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure
eLife 7:e35832.
https://doi.org/10.7554/eLife.35832

Share this article

https://doi.org/10.7554/eLife.35832

Further reading

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.